DARWIN studies performed to date

Completed studies, n=15

First Page of Factsheet

P2-C3-004: DARWIN EU® - Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer

First Page of Factsheet

P3-C1-001: DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study

First Page of Factsheet

P3-C2-002: DARWIN EU® - RR1 Drug Utilisation Study of prescription opioids

P3-C3-001: DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

First Page of Factsheet

P3-C3-008: DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives

First Page of Factsheet

P4-C1-008: DARWIN EU® - Drug utilisation study in individuals with cystic fibrosis in Europe

First Page of Factsheet

P4-C2-002: DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics

First Page of Factsheet

P4-C2-003: DARWIN EU® - Antipsychotic prescribing in children in Europe: a descriptive analysis of trends and patient characteristics

First Page of Factsheet

P4-C2-006: DARWIN EU® - Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications

First Page of Factsheet

P4-C2-007: DARWIN EU® - RR Characterisation of individuals with cystic fibrosis in Europe

First Page of Factsheet

P3-C3-009: DARWIN EU® – Utilisation of commonly used benzodiazepines during pregnancy and the incidence of pregnancy losses

First Page of Factsheet

P4-C2-010: DARWIN EU® - Characterizing Obesity in Norwegian Linked Health Registry Data

First Page of Factsheet

P3-C1-018: DARWIN EU® – Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in Norway

First Page of Factsheet

P4-C2-012: DARWIN EU® - Utilization of sartans in children and adolescents in Norway

First Page of Factsheet
 

P3-C1-020: DARWIN EU® - Utilization of antiretroviral therapies in pediatric patients in Norway

First Page of Factsheet

P4-C1-016: Darwin EU® - Annual seasonal influenza vaccine effectiveness

First Page of Factsheet

 P4-C2-016: DARWIN EU® - Capturing suicidality and depression related variables in databases

First Page of Factsheet

P4-C2-018: DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

First Page of Factsheet

P4-C2-013/P4-C2-014: DARWIN EU® - Determinants for use of GLP1 receptor agonists – a drug utilisation study

 

 

Factsheets coming soon:

Published June 22, 2026 1:46 PM - Last modified Oct. 7, 2026 9:43 AM